Your browser doesn't support javascript.
loading
Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment.
Grudda, Tanner; Hwang, Hyon S; Taddese, Maraake; Quinn, Jeffrey; Sulkowski, Mark S; Sterling, Richard K; Balagopal, Ashwin; Thio, Chloe L.
Affiliation
  • Grudda T; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Hwang HS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Taddese M; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Quinn J; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sulkowski MS; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sterling RK; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Balagopal A; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Thio CL; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
J Clin Invest ; 132(18)2022 09 15.
Article in En | MEDLINE | ID: mdl-35797115
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Hepatitis B Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis B, Chronic / Hepatitis B Limits: Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication: